NRG
40
3
DTE
47
-2
SE
63
5
AME
54
-5
TSN
32
-3
FOX
53
-2
PH
66
2
URBN
70
-2
C
60
-2
PSA
51
-2
DG
21
-6
CSX
48
-5
EXC
51
-2
SJM
21
-3
TROW
54
-2
AZO
58
-2
HCA
44
-2
CHD
34
-5
GOOG
87
6
AKAM
61
3
NRG
40
3
DTE
47
-2
SE
63
5
AME
54
-5
TSN
32
-3
FOX
53
-2
PH
66
2
URBN
70
-2
C
60
-2
PSA
51
-2
DG
21
-6
CSX
48
-5
EXC
51
-2
SJM
21
-3
TROW
54
-2
AZO
58
-2
HCA
44
-2
CHD
34
-5
GOOG
87
6
AKAM
61
3
Financhill
Back

Serina Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
33

SER
Serina Therapeutics

Last Price:
4.80
Seasonality Move:
3.68%
Sell
16

NBY
NovaBay Pharmaceuticals

Last Price:
0.54
Seasonality Move:
-8.54%
Sell
33
Serina Therapeutics (SER) is a Sell

Is Serina Therapeutics a Buy, Sell or Hold?

  • The current Serina Therapeutics [SER] share price is $4.76. The Score for SER is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • SER is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
16
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.53. The Score for NBY is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

SER Stock Price Chart

What is Serina Therapeutics's stock price today?

  • The Serina Therapeutics share price today is $4.76
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SER is experiencing selling pressure, which indicates risk of future bearish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing selling pressure, which indicates risk of future bearish movement.

SER Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 41.28 Sell
Chaikin Money Flow: -13283 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.68 - 5.44) Sell
Bollinger Bands (100): (5.52 - 8.28) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 32.51 Sell
Chaikin Money Flow: -111892 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.58 - 0.72) Sell
Bollinger Bands (100): (0.35 - 0.97) Sell

SER Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.34 Sell
20-day SMA: 5.09 Sell
50-day SMA: 6.04 Sell
200-day SMA: 8.75 Sell
8-day EMA: 5.2 Sell
20-day EMA: 5.3 Sell
50-day EMA: 5.89 Sell
200-day EMA: 9.06 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.58 Sell
20-day SMA: 0.64 Sell
50-day SMA: 0.65 Sell
200-day SMA: 2.04 Sell
8-day EMA: 0.58 Sell
20-day EMA: 0.62 Sell
50-day EMA: 0.68 Sell
200-day EMA: 5 Sell

Serina Therapeutics Earnings Growth & SER Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Serina Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):